(Bloomberg) -- Moderna Inc. said it acted immediately to remove Jorge Gomez as chief financial officer earlier this week after it learned of an investigation related to the handling of incentives at his former company.
Moderna said Friday that it learned of the probe at Dentsply Sirona Inc., where Gomez had previously been CFO, only when the maker of dental instruments and systems publicly disclosed an internal investigation on Tuesday morning, the day after Gomez started at Moderna.
“Within one hour” of learning about the inquiry, Moderna Chief Executive Officer Stephane Bancel met with external and internal lawyers and board chair Noubar Afeyan to decide how to proceed. The full board was convened for a special meeting later that day, the company said in a statement.
“Upon meeting, the board made the determination that it was appropriate to separate Mr. Gomez from Moderna,” the company said. “Mr. Gomez was immediately informed of that decision.”
Moderna announced Gomez’s departure the next morning, on May 11. Moderna said Friday that it was “unaware of the investigation until it was publicly disclosed,” and that it was confident it had conducted appropriate due diligence prior to the hiring of Gomez, including contacting former employers, which revealed no concerns.
Shares of Moderna, which have been under pressure this year, gained 5.3% on Friday in New York.
Gomez, 54, had served as CFO for Dentsply Sirona for almost three years before leaving for Moderna. The Charlotte, North Carolina-based company said Tuesday that it hasn’t finalized its assessment of the impact of the probe on its older financial statements or those for the first quarter, and will delay filing its 10-Q for the period.
©2022 Bloomberg L.P.